The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers.
COVID-19
ORCHESTRA
SARS-CoV-2
antibodies
breakthrough infections
health care workers
immunologic response
seroprevalence
vaccination
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
18 07 2023
18 07 2023
Historique:
received:
14
06
2023
revised:
11
07
2023
accepted:
15
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Antibody studies analyze immune responses to SARS-CoV-2 vaccination and infection, which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted between 16 June and 16 December 2021, 6088 participants aged 18 and above from Munich were recruited to monitor antibodies, particularly in healthcare workers (HCWs) at higher risk of infection. Roche Elecsys
Identifiants
pubmed: 37515259
pii: v15071574
doi: 10.3390/v15071574
pmc: PMC10383736
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Front Immunol. 2023 Jan 09;13:1035441
pubmed: 36700198
EBioMedicine. 2021 Aug;70:103502
pubmed: 34333234
Nat Commun. 2021 Nov 4;12(1):6379
pubmed: 34737312
J Gen Virol. 2021 Oct;102(10):
pubmed: 34623233
Lancet Reg Health Eur. 2022 Sep 23;22:100501
pubmed: 36168404
BMC Infect Dis. 2022 Jan 9;22(1):41
pubmed: 35000580
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709
pubmed: 33400782
Viruses. 2022 May 27;14(6):
pubmed: 35746640
Infect Dis Ther. 2021 Sep;10(3):1505-1518
pubmed: 34137000
Crit Rev Clin Lab Sci. 2022 Sep;59(6):373-390
pubmed: 35220860
Int J Environ Res Public Health. 2021 Mar 30;18(7):
pubmed: 33808249
Int J Environ Res Public Health. 2022 Dec 17;19(24):
pubmed: 36554876
Infection. 2023 Feb;51(1):83-90
pubmed: 35648370
Front Microbiol. 2020 Oct 19;11:584251
pubmed: 33193227
Trop Med Infect Dis. 2022 Jan 13;7(1):
pubmed: 35051125
J Med Virol. 2023 Jan;95(1):e28300
pubmed: 36369641
BMJ Evid Based Med. 2021 Dec;26(6):279-284
pubmed: 32788164
Infect Dis Poverty. 2022 May 13;11(1):53
pubmed: 35562753
Int J Environ Res Public Health. 2022 Aug 29;19(17):
pubmed: 36078466
J Med Virol. 2022 Jul;94(7):2939-2961
pubmed: 35229324
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
EBioMedicine. 2022 Jan;75:103805
pubmed: 35032961
Elife. 2020 Sep 07;9:
pubmed: 32894217
Emerg Microbes Infect. 2023 Dec;12(1):e2164219
pubmed: 36583642
Emerg Microbes Infect. 2022 Dec;11(1):1262-1271
pubmed: 35412409
J Clin Virol. 2021 Mar;136:104765
pubmed: 33636554
Int J Mol Sci. 2022 Jul 30;23(15):
pubmed: 35955621
Sci Rep. 2022 May 23;12(1):8679
pubmed: 35606426
BMC Med. 2022 Nov 25;20(1):461
pubmed: 36434597
J Clin Epidemiol. 2006 Oct;59(10):1092-101
pubmed: 16980150
BMC Infect Dis. 2023 Jul 13;23(1):466
pubmed: 37442952
Tob Use Insights. 2021 Feb 15;14:1179173X21994612
pubmed: 33642886
BMC Public Health. 2020 Jun 30;20(1):1036
pubmed: 32605549
PLoS One. 2022 Nov 21;17(11):e0277827
pubmed: 36409702
BMC Infect Dis. 2021 Sep 8;21(1):925
pubmed: 34493217
Nat Rev Immunol. 2002 May;2(5):372-7
pubmed: 12033743
Vaccine. 2023 Apr 6;41(15):2596-2604
pubmed: 36932031
Saf Health Work. 2022 Sep;13(3):263-268
pubmed: 35433073
Viruses. 2021 Jun 10;13(6):
pubmed: 34200766
Front Immunol. 2022 Sep 29;13:986085
pubmed: 36248889
Vaccines (Basel). 2022 Feb 16;10(2):
pubmed: 35214761
J Med Virol. 2022 Oct;94(10):4719-4726
pubmed: 35655438
Vaccines (Basel). 2022 May 18;10(5):
pubmed: 35632554
Vaccines (Basel). 2022 Jul 27;10(8):
pubmed: 36016081